scholarly journals Indoor Tanning and the Risk of Overall and Early-Onset Melanoma and Non-Melanoma Skin Cancer: Systematic Review and Meta-Analysis

Cancers ◽  
2021 ◽  
Vol 13 (23) ◽  
pp. 5940
Author(s):  
Seokyung An ◽  
Kyungsik Kim ◽  
Sungji Moon ◽  
Kwang-Pil Ko ◽  
Inah Kim ◽  
...  
Keyword(s):  
Systematic Review ◽  
Skin Cancer ◽  
Cell Carcinoma ◽  
Early Onset ◽  
Meta Analysis ◽  
Indoor Tanning ◽  
Non Melanoma Skin Cancer ◽  
Annual Frequency ◽  
Summary Relative Risk ◽  
Melanoma Skin

The aim of this study was to examine the association between indoor tanning use and the risk of overall and early-onset (age < 50) melanoma and non-melanoma skin cancer (NMSC). To evaluate the association between indoor tanning and skin cancer, a systematic review of the literature published until July 2021 was performed using PubMed, EMBASE, and MEDLINE. Summary relative risk (RR) from 18 studies with 10,406 NMSC cases and 36 studies with 14,583 melanoma cases showed significant association between skin cancer and indoor tanning (melanoma, RR= 1.27, 95% CI 1.16–1.39; NMSC, RR = 1.40, 95% CI 1.18–1.65; squamous cell carcinoma (SCC), RR = 1.58, 95% CI 1.38–1.81; basal cell carcinoma (BCC), RR = 1.24, 95% CI 1.00–1.55). The risk was more pronounced in early-onset skin cancer (melanoma, RR = 1.75, 95% CI 1.14–2.69; NMSC, RR = 1.99, 95% CI 1.48–2.68; SCC, RR = 1.81, 95% CI 1.38–2.37; BCC, RR = 1.75, 95% CI 1.15–2.77). Moreover, first exposure at an early age (age ≤ 20 years) and higher exposure (annual frequency ≥ 10 times) to indoor tanning showed increasing risk for melanoma (RR = 1.47, 95% CI 1.16–1.85; RR = 1.52, 1.22–1.89) and NMSC (RR = 2.02, 95% CI 1.44–2.83; RR = 1.56, 95% CI 1.31–1.86). These findings provide evidence supporting primary prevention policies regulating modifiable behaviors to reduce the additional risk of skin cancer among younger adults.

scholarly journals Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis

BMJ ◽  
2012 ◽  
Vol 345 (oct02 3) ◽  
pp. e5909-e5909 ◽  
Author(s):  
M. R. Wehner ◽  
M. L. Shive ◽  
M.-M. Chren ◽  
J. Han ◽  
A. A. Qureshi ◽  
...  
Keyword(s):  
Systematic Review ◽  
Skin Cancer ◽  
Meta Analysis ◽  
Indoor Tanning ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

scholarly journals Risk of non-melanoma skin cancer in patients with psoriasis: An updated evidence from systematic review with meta-analysis

2020 ◽  
Vol 11 (5) ◽  
pp. 1047-1055 ◽  
Author(s):  
Xiujuan Wang ◽  
Qiang Liu ◽  
Lingling Wu ◽  
Zhenhua Nie ◽  
Zubing Mei
Keyword(s):  
Systematic Review ◽  
Skin Cancer ◽  
Meta Analysis ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

Risk of non-melanoma skin cancer for rheumatoid arthritis patients receiving TNF antagonist: a systematic review and meta-analysis

2019 ◽  
Vol 39 (3) ◽  
pp. 769-778 ◽  
Author(s):  
Jiang-lin Wang ◽  
Wen-jun Yin ◽  
Ling-yun Zhou ◽  
Ge Zhou ◽  
Kun Liu ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Systematic Review ◽  
Skin Cancer ◽  
Meta Analysis ◽  
Non Melanoma Skin Cancer ◽  
Tnf Antagonist ◽  
Melanoma Skin

Use of sunscreen and risk of melanoma and non-melanoma skin cancer: a systematic review and meta-analysis

2018 ◽  
Vol 28 (2) ◽  
pp. 186-201 ◽  
Author(s):  
Elizabet saes da Silva ◽  
Roberto Tavares ◽  
Felipe da silva Paulitsch ◽  
Linjie Zhang
Keyword(s):  
Systematic Review ◽  
Skin Cancer ◽  
Meta Analysis ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

Laser Treatment for Non-Melanoma Skin Cancer: A Systematic Review and Meta-Analysis

2020 ◽  
Author(s):  
Eran Sharon ◽  
Igor Snast ◽  
Moshe Lapidoth ◽  
Ran Kaftory ◽  
Daniel Mimouni ◽  
...  
Keyword(s):  
Systematic Review ◽  
Skin Cancer ◽  
Laser Treatment ◽  
Meta Analysis ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

Variation in Skin Cancer Pattern in the Southwestern Region of Pakistan

2021 ◽  
Vol 15 (12) ◽  
pp. 3402-3404
Author(s):  
Hina , Manzoor ◽  
Najeeb Ahmad ◽  
Zafar H Tanveer ◽  
Khush Naseed Ahmed ◽  
Munir , Ahmed ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Skin Cancer ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Published Data ◽  
Non Melanoma Skin Cancer ◽  
Broad Term ◽  
The Difference ◽  
Field Workers ◽  
Melanoma Skin

Background: Skin cancer is a broad term that refers to a variety of different types of cancer. It is usually recognized as non-melanoma and melanoma skin cancer. In many parts of the world, the prevalence is high, with significant ecological and ethical variation. Objectives: Objective was to determine demographic and histological features of skin cancer in Southwest region of Pakistan. Methodology: This retrospective study was carried out on skin cancer 1169 cases of Centre for Nuclear Medicine and Radiotherapy (CENAR) in Quetta. The data from January 2000 to December 2009 (10Years) was retrieved from record. The aim was to determine the importance of skin cancer in this area, its gender wise distribution and its pathological types. Results: Record of total 9308 cancer patients was retrieved from patients presenting to CENAR Quetta. From 9308 case, 1169(12.5%) patients were of skin cancer which was second most prevalent category of cancer in this area. Prevalence was higher in males with 713(61%) cases as compared to females. Pathologically with 634(54%) cases, the most prevalent category was Squamous cell carcinoma (SCC). Conclusion: Skin cancer is wide-spread type of cancer in patients of south-west region of Pakistan. The findings of this study are not aligned with published data. The difference is because of high altitude of the study area, dry climate and long skin exposure particularly in low socio-economic field workers. Keywords: Skin cancer, gender, Melanoma skin cancer (MSC), Squamous cell carcinoma (SCC), Non-melanoma skin cancer (NMSC), Basal cell carcinoma (BCC),

Surgical Management of Melanoma and Other Skin Cancers

2015 ◽  
Author(s):  
Jennifer A. Wargo ◽  
Kenneth Tenabe
Keyword(s):  
Lymph Node ◽  
Surgical Treatment ◽  
Skin Cancer ◽  
Cell Carcinoma ◽  
Stage Iv ◽  
Stage Iii ◽  
Non Melanoma Skin Cancer ◽  
Skin Cancers ◽  
Stage Iv Melanoma ◽  
Melanoma Skin

The prevalence of malignant skin cancers has increased significantly over the past several years. Approximately 1.2 million cases of non-melanoma skin cancer are diagnosed per year. More alarming, up to 80,000 cases of melanoma are diagnosed per year, an incidence that has been steadily increasing, with a lifetime risk of 1 in 50 for the development of melanoma. The disturbing increase in the incidence of both non-melanoma skin cancer and melanoma can largely be attributed to the social attitude toward sun exposure. The clinical assessment and management of skin lesions can be challenging. This review describes the assessment process, including thorough history and examination; the need for possible biopsy; and excision criteria. Specific types of skin cancer are distinguished and include basal cell carcinoma; squamous cell carcinoma; and melanoma; and for each type the incidence; epidemiology; histologic subtypes; diagnosis; and both surgical and non-surgical treatments are provided. Stages I-IV of melanoma are detailed, with prognostic factors described. Surgical treatment for stages I and II include description of the margins of excision and sentinel lymph node biopsy. The surgical treatment of Stage III melanoma further includes therapeutic lymph node dissection and isolated limb perfusion. Adjuvant therapies are also presented and include radiotherapy and chemotherapy. The additional treatment of metastasectomy for Stage IV melanoma is described. For both Stage III and IV melanoma, the study of vaccines to host immune cells is reported. For Stage IV melanoma, the text also describes immunotherapy treatment. Operative procedures specific to superficial and deep groin dissections are outlined. This review contains 9 figures, 3 tables, and 96 references.

Sign in / Sign up

Export Citation Format

Share Document